Langconoy, Wilfredo L.

HRN: 21-51-49  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/30/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/30/2022
07/07/2022
IV INFUSION
4.5g
Q6
Increasing WBC Trend; Pustular Discharges; Pulmonary Infiltrates
Waiting Final Action 

Indication:  EmpiricEmpirical Escalation    Type of Infection:  PneumoniaBloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: